COVID-19 symptoms.The agency announced the decision in a press release Tuesday morning, saying this is the first drug Health Canada has authorized for the treatment of COVID-19.
U.S. buys up worldwide stock of remdesivir, drug seen as potential COVID-19 treatment The drug is to be used in patients with severe pneumonia symptoms as a result of their coronavirus infection, and who require supplemental oxygen to breathe.Health Canada is authorizing its use in adults and adolescents over the age of 12.
The drug manufacturer, Gilead, did not seek to have it authorized for use in pregnant women or children.The drug is approved with conditions that require Gilead to continue to monitor its safety and efficacy.The U.S., Singapore, Japan,.